BTC1.04 Genomic profiling of IDH-wildtype and IDH-mutant initial and matched recurrent glioblastomas reveals clinically actionable mutations (e.g. BRCA1/2) and resistance signatures

BACKGROUND: Glioblastomas account for 90% of all adult brain tumours. Patient survival remains low because treatments are ineffective against this lethal disease. Understanding the genes and pathways altered in subtypes is necessary for therapeutic intervention. MATERIAL AND METHODS: Tumours from 41...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: McInerney, C E, Ellis, H P, Schrimpf, D, Sahm, F, Stupnikov, A, Wadsley, M, Wragg, C, White, P, Prise, K M, McArt, D G, Kurian, K M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2018
Matèries:
Oral Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144622/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars